Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 18:35:80-83.
doi: 10.1016/j.jdcr.2023.03.005. eCollection 2023 May.

Calciphylaxis in a pediatric patient with multisystem inflammatory syndrome

Hanna L Distel  1 , Prashant J Purohit  1 , Susan E Ingraham  1 , Andrew K Feng  1
Affiliations
Case Reports

Calciphylaxis in a pediatric patient with multisystem inflammatory syndrome

Hanna L Distel et al. JAAD Case Rep. .
No abstract available

Keywords: COVID-19; MIS-C; SARS-CoV-2; T2DM; calciphylaxis; hypercalcemia; inflammation; multisystem inflammatory syndrome in children; obesity; pediatric; rapid weight loss; renal failure; sodium thiosulfate; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Early calciphylaxis lesions with violaceous discoloration on hospital day 110. A, Left proximal aspect of the thigh. B, Left distal aspect of the thigh.
Fig 2
Fig 2
Progression of calciphylaxis in right side of the thigh to eschar formation and subsequent fat necrosis. A, Hospital day 200. B, Hospital day 250.
Fig 3
Fig 3
Left side of the thigh punch biopsy sample image taken on hospital day 200. A, Calcified elastic fibers stained dark (yellow circle). B, Calcium in arteriole wall (arrow). (A and B, Von Kossa stain; original magnification: A, ×4; B, ×10).
Fig 4
Fig 4
A, Abdominal lesion before STS, 5 and 10 weeks after STS administration, and at 15 weeks upon discontinuing STS. B, Right medial proximal aspect of the thigh 0, 5, 10 weeks after STS administration, and at 15 weeks upon discontinuing STS. C, Left medial middle area of the thigh 0, 5, 10 weeks after STS administration, and at 15 weeks upon discontinuing STS. STS, Sodium thiosulfate.
See this image and copyright information in PMC

References

    1. Fine A., Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome, and therapy. Kidney Int. 2002;61:2210–2217. - PubMed
    1. Nigwekar S.U., Kroshinsky D., Nazarian R.M., et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66(1):133–146. - PMC - PubMed
    1. Feng J., Gohara M., Lazova R., Antaya R.J. Fatal childhood calciphylaxis in a 10-year-old and literature review. Pediatr. Dermatol. 2006;23(3):266–272. - PubMed
    1. Nigwekar S.U., Wolf M., Sterns R.H., Hix J.K. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3(4):1139–1143. - PMC - PubMed
    1. Don B.R., Chin A.I. A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol. 2003;59(6):463–470. - PubMed

Publication types